Ferroportin Q248H mutation, hyperferritinemia and atypical type 2 diabetes mellitus in South Kivu

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 7, Issue 2, 2013, Pages 112-115

  Katchunga, Philippe Bianga ^a   Baguma, Marius ^a   M'Buyamba Kabangu, Jean René ^a   Philippé, Jan ^c   Hermans, Michel P ^b   Delanghe, Joris ^a,c  

^a CATHOLIC UNIVERSITY OF BUKAVU   (Democratic Republic Congo)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Diabetes; Ferroportin; Hyperferritinemia; Mellitus; South Kivu

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; FERROPORTIN; IRON; TRANSFERRIN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HUMAN; HYPERFERRITINEMIA; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; CATARACT; CATION TRANSPORT PROTEINS; CROSS-SECTIONAL STUDIES; DEMOCRATIC REPUBLIC OF THE CONGO; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IRON METABOLISM DISORDERS; MALE; MIDDLE AGED; MUTATION;

EID: 84877787906     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2013.02.017     Document Type: Article

References (29)

1. E. Sobngwi, F. Mauvais-Jarvis, P. Vexiau, J.C. Mbanya, and J.F. Gautier Diabetes in Africans. Part 1. Epidemiological and clinical specificities Diabetes and Metabolism 27 2001 628 634
2. P. Katchunga, B. Masumbuko, M. Belma, Z. Kashongwe Munogolo, M.P. Hermans, and J.R. M'Buyamba-Kabangu Age and living in an urban environment as major determinants of prevalent diabetes mellitus among South-Kivu Congolese adults Diabetes and Metabolism 38 2012 324 331
3. F. Mauvais-Jarvis, E. Sobngwi, R. Porcher, J.P. Riveline, J.P. Kevorkian, and C. Vaisse Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance Diabetes 53 2004 645 653
4. E. Sobngwi, F.F. Mauvais-Jarvis, P. Vexiau, J.C. Mbanya, and J.F. Gautier Diabetes in Africans. Part 2. Ketosis prone atypical diabetes mellitus Diabetes and Metabolism 28 2002 5 12
5. G.E. Umpierrez, D. Smiley, and A.E. Kitabchi Narrative review: ketosis-prone type 2 diabetes mellitus Annals of Internal Medicine 144 2006 350 357
6. E. Sobngwi, S.P. Choukem, F. Agbalika, B. Blondeau, L.S. Fetita, and C. Lebbe Ketosis prone type 2 diabetes and human herpes virus 8 infection in sub-Saharan Africans Journal of the American Medical Association 299 2008 2770 2776
7. T.F. Schulz Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis Journal of Antimicrobial Chemotherapy 45 Suppl. 3 2000 15 27
8. T. Simonart Iron: a target for the management of Kaposi's sarcoma? BMC Cancer 4 2004 1 8
9. J.L. Ziegler Endemic Kaposi's sarcoma in Africa and local volcanic soils Lancet 342 1993 1348 1351
10. L. Sun, O.H. Franco, F.B. Hu, L. Cai, Z. Yu, and H. Li Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese Journal of Clinical Endocrinology and Metabolism 93 December (12) 2008 4690 4696
11. D. Albuquerque, L. Manco, K.M. Loua, A.P. Arez, M.J. Trovoada, and L. Relvas SLC40A1 Q248H allele frequencies and associated SLC40A1 haplotypes in three West African population samples Annals of Human Biology 38 3 2011 378 381
12. J.C. Barton, R.T. Acton, P.L. Lee, and C. West SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent Blood Cells, Molecules, and Diseases 39 2007 206 211
13. J.C. Barton, R.T. Acton, C.A. Rivers, L.F. Bertoli, T. Gelbart, C. West, and E. Beutler Genotypic and phenotypic heterogeneity of African Americans with primary iron overload Blood Cells, Molecules, and Diseases 31 2003 310 319
14. E. Beutler, J.C. Barton, V.J. Felitti, T. Gelbart, C. West, P.L. Lee, J. Waalen, and C. Vulpe Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans Blood Cells, Molecules, and Diseases 31 2003 305 309
15. V.R. Gordeuk, A. Caleffi, E. Corradini, F. Ferrara, R.A. Jones, and O. Castro Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene Blood Cells, Molecules, and Diseases 31 2003 299 304
16. F. Masaisa, C. Breman, J.B. Gahutu, J. Mukiibi, J. Delanghe, and J. Philippé Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating serum hepcidin levels in Rwandese HIV-positive women Annals of Hematology 91 2012 911 916
17. W.T. Friedewald, R.I. Levy, and D.S. Frederickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clinical Chemistry 18 1972 499 502
18. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 35 Suppl. 2012 S64 S71
19. World Health Organization/United Nations Children's Fund/United Nations University 2001 Iron deficiency anaemia. Assessment, prevention and control: a guide for programme managers, WHO/NHD/01.3. Geneva: World Health Organization.
20. K.G. Alberti, P. Zimmet, and J. Shaw IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition Lancet 366 2005 1059 1062
21. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood Pressure: the JNC 7 report Journal of the American Medical Association 289 2003 2560 2572
22. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, and K.A. Donato Harmonizing the Metabolic Syndrome. A joint interim statement of the I.D.F. Task Force on Epidemiology and Prevention; N.H.L. and Blood Institute; A.H.A; W.H.F; I.A.S; and I.A. for the study of obesity Circulation 120 2009 1640 1645
23. R. Mayr, A.R. Janecke, M. Schranz, W.J.H. Griffiths, W. Vogel, and A. Pietrangelo Ferroportin disease: a systematic meta-analysis of clinical and molecular findings Journal of Hepatology 53 2010 941 949
24. A.M. Jouanolle, V. Douabin-Gicquel, C. Halimi, O. Loréal, P. Fergelot, and T. Delacour Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload Journal of Hepatology 39 2003 286 289
25. M. Beaton, D. Guyader, Y. Deugnier, R. Moirand, S. Chakrabarti, and P. Adams Noninvasive prediction of cirrhosis in C282Y linked hemochromatosis Hepatology 36 2002 673 678
26. E.D. Morrison, D.J. Brandhagen, P.D. Phatak, J.C. Barton, E.L. Krawitt, and H.B. El-Serag Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis Annals of Internal Medicine 138 2003 627 633
27. P.C. Adams, D.M. Reboussin, J.C. Barton, E. Christine, C.E. McLaren, and H. John Hemochromatosis and iron-overload screening in a racially diverse population New England Journal of Medicine 352 2005 1769 1778
28. R. Damade, E. Rosenthal, and P. Cacoub Les hyperferritinémies Ann Med Interne 151 2000 169 177
29. P. Katchunga, M.P. Hermans, B. Manwa, F. Lepira, Z. Kashongwe, and J.R. M'Buyamba-Kabangu Hypertension, insulin resistance and chronic kidney disease in type 2 diabetes patients from South Kivu, DR Congo Nephrologie & Therapeutique 6 2010 520 525